|Realord Group Holdings Limited -- Germany Stock|| |
EUR 0.62 0.00 0.00%
CFO, Company Secretary
Mr. Darren M. Keamy, BComm, CPA, serves as Company Secretary and Chief Financial Officer of Clinuvel Pharmaceuticals Ltd. He is Certified Practicing Accountant, joined Clinuvel Pharmaceuticals Limited November 2005 and became Chief Financial Officer of the Company in 2006.
CFO Since 2006 CPA
The company has return on total asset (ROA)
of (1.97) %
which means that it has lost $1.97 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE)
of 8.71 %
meaning that it generated $8.71 on every $100 dollars invested by stockholders.
The company has accumulated 75.95 M in total debt with debt to equity ratio (D/E) of 57.6 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Realord Group Holdings Limited has Current Ratio of 1.22 suggesting that it is in a questionable position to pay out its financial obligations in time and when they become due.
Realord Group Holdings Limited (CUV) is traded on Frankfurt Stock Exchange in Germany. and employs 7 people.